Total Copper and Labile Bound Copper Fraction as a Selective and Sensitive Tool in the Evaluation of Wilson Disease

Bornhorst, Joshua A
Bitzer, Anna C
Day, Patrick L
Wermers, Michelle
Smith, Carin Y
Pazdernik, Vanessa K
Pelto, Ryan
Sankaran, Banu
Quicquaro, Adam
Jannetto, Paul J

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States
Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, United States
Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, United States
Alexion Pharmaceuticals/Astra Zeneca, Rare Disease Unit, New Haven, CT, United States
Alexion Pharmaceuticals/Astra Zeneca, Rare Disease Unit, Boston, MA, United States
Alexion Pharmaceuticals/Astra Zeneca, Rare Disease Unit, Boston, MA, United States
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States

Address correspondence to this author at: Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, United States. Tel (507)-293-0142; e-mail [email protected].

Received April 17, 2024

Accepted July 10, 2024

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/pages/standard-publication-reuse-rights)

The Journal of Applied Laboratory Medicine 9(6):p 1014-1027, November 2024. | DOI: 10.1093/jalm/jfae090